(Q45978317)

18 December 2017

title

Personalized prostate cancer screening: improving PSA tests with genomic information. (English)

1 reference

18 December 2017

prostate cancer screening

main subject

1 reference

John S Witte

1

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

18 December 2017

Science Translational Medicine

published in

1 reference

18 December 2017

volume

2

1 reference

18 December 2017

issue

62

1 reference

18 December 2017

page(s)

62ps55

1 reference

18 December 2017

Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Screening for prostate cancer--the controversy that refuses to die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Prostate specific antigen best practice statement: 2009 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Genetic correction of PSA values using sequence variants associated with PSA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Prostate cancer screening: current status and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

21 January 2018

Overdiagnosis in cancer

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Impact of Common Medications on Serum Total Prostate-Specific Antigen Levels: Analysis of the National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Multiple newly identified loci associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Multiple loci identified in a genome-wide association study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Performance of common genetic variants in breast-cancer risk models

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

Prostate specific antigen for early detection of prostate cancer: longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001861

10.1126/SCITRANSLMED.3001861

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017